The SLC20A2 gene helps move phosphate into cells, especially in the brain, which supports normal mineral balance. If this gene does not work well, calcium phosphate can build up in parts of the brain over time. People with a disease-causing variant may develop primary familial brain calcification, which can be linked to tremor, stiffness, balance problems, headaches, mood changes, or memory symptoms, while some never notice clear symptoms. Most people first hear about this gene during testing for unexplained brain calcifications that run in families.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or guiding activities in the body. Some carry the code for proteins, which do much of the cell’s work. Others are used mainly to regulate when a process happens, where it happens, and how active it is. In combination, genes affect how your body grows and works, and they can also influence how you react to food, stress, and medicines. For a deeper look at this subject, visit the LearnHub.
Overview
SLC20A2Gene function
What if the gene works
The SLC20A2 gene helps move phosphate into cells. This supports normal mineral balance and cell signaling, especially in the brain. When this transport works well, tissues are less likely to build up extra calcium phosphate.
Risk
What if the gene does not work
Pathogenic variants in the SLC20A2 gene can cause primary familial brain calcification, with calcium deposits in deep brain areas. Effects range from none to movement symptoms, headaches, mood changes, or thinking problems, and severity varies by variant.
Treatment
What does that mean for your treatment
For a pathogenic variant in the SLC20A2 gene, no treatment or drug choice approach specific to the SLC20A2 gene is currently established. Care is based on a person’s symptoms, and the SLC20A2 gene is mainly being studied in early research on phosphate handling and brain calcification.
Conditions associated with SLC20A2
Gene function
What if the gene works
Your cells need a steady supply of phosphate, a mineral used in energy, cell membranes, and genetic material. The SLC20A2 gene helps move this phosphate from body fluids into cells. Knowing what the SLC20A2 gene does in the body helps explain how cells keep routine work going each day.
The SLC20A2 gene helps cells bring phosphate in from their surroundings. It uses sodium as a partner in this transport, which helps maintain a steady phosphate supply inside the cell.
Cells need phosphate to make ATP, the main molecule they use for energy. By supplying phosphate, this gene supports everyday cell work such as movement, signaling, and basic cell upkeep.
Phosphate is part of DNA, RNA, and the membranes that surround cells. This means the SLC20A2 gene helps provide material your cells use to grow, divide, and communicate.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC20A2 gene often reduce or block the cell's ability to move phosphate, either by changing the protein's shape, making it unstable, or stopping it from reaching the cell surface. Milder variants may leave some transport activity, while more severe variants can nearly abolish it. This link between SLC20A2 gene variants and brain calcification reflects the degree of lost transport and can influence whether primary familial brain calcification appears earlier or with more features, although this varies.
How variants are linked to conditions
Pathogenic variants in the SLC20A2 gene cause primary familial brain calcification, a condition historically called Fahr disease. Some people develop tremor, stiffness, balance problems, headaches, seizures, or changes in mood or thinking, while others have few or no symptoms. Among conditions linked to SLC20A2 gene variants, primary familial brain calcification is the best-established finding.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, particularly when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC20A2, risk is mainly shaped by whether a disease-causing gene change is present, and symptoms can vary even within the same family. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce the chance of developing related brain calcification, so regular medical follow-up is often the most useful step.
Inheritance of SLC20A2 variants
SLC20A2-related primary familial brain calcification is usually inherited in an autosomal dominant pattern, which means a child can inherit the gene change from one affected parent. If a parent carries a disease-causing variant in the SLC20A2 gene, each pregnancy has a 50% chance of passing it on. This is the key point in understanding how SLC20A2 variants are inherited in families. Men and women can inherit and pass on the variant equally.
What does my SLC20A2 result mean for my family?
Changes in the SLC20A2 gene are most often passed through families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to learn whether it is present in them. In a family where one parent carries the change, each child has a 1 in 2 chance of inheriting it. Some cases can start new in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC20A2 variants usually uses a blood or saliva sample. A lab reads the SLC20A2 gene to look for changes that may help explain brain calcification seen on scans or a family history. Results can show a disease-causing variant, no relevant variant, or a finding of uncertain meaning.
When should I consider getting a genetic test?
Genetic testing for the SLC20A2 gene may be worth considering if brain scans show calcium buildup in deep parts of the brain, especially when this runs in the family or comes with movement problems, seizures, migraines, mood changes, or memory problems. A result can help explain the cause and clarify whether relatives may also carry the change.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it clarifies depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Small differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. By looking at gene-drug relationships, it helps explain why the same treatment can work differently from one person to another. For many medications, genes influence both how the body handles a drug and how strong its effects may be. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC20A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how your medicines may affect you are best discussed with your doctor.
History
For many years, doctors described families in which calcium built up in deep parts of the brain across generations, often without a clear cause. In 2012, researchers linked many of these cases to variants in the SLC20A2 gene, giving a clearer genetic explanation for what had often been called idiopathic basal ganglia calcification or Fahr disease. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery helped separate inherited cases from other causes of brain calcification. From these first observations, research expanded steadily. The finding also led to the newer term primary familial brain calcification, which better reflects the inherited nature of the condition. Since then, the SLC20A2 gene has remained one of the main genes studied in this field.